ID: ALA201076

Max Phase: Preclinical

Molecular Formula: C12H16N2O

Molecular Weight: 204.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OCCCNC1=Nc2ccccc2CC1

Standard InChI:  InChI=1S/C12H16N2O/c15-9-3-8-13-12-7-6-10-4-1-2-5-11(10)14-12/h1-2,4-5,15H,3,6-9H2,(H,13,14)

Standard InChI Key:  UYEBOGZNRNYEJV-UHFFFAOYSA-N

Associated Targets(non-human)

Phosphodiesterase 1 205 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 204.27Molecular Weight (Monoisotopic): 204.1263AlogP: 1.63#Rotatable Bonds: 3
Polar Surface Area: 44.62Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.57CX LogP: 1.04CX LogD: -0.60
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.74Np Likeness Score: -0.12

References

1. Delcros JG, Tomasi S, Duhieu S, Foucault M, Martin B, Le Roch M, Eifler-Lima V, Renault J, Uriac P..  (2006)  Effect of polyamine homologation on the transport and biological properties of heterocyclic amidines.,  49  (1): [PMID:16392808] [10.1021/jm050018q]

Source